Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP387076.RA5NQpdk_eD9_ElhxD-D1S65NxuGUc-gjJ5aHRGkAftv0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP387076.RA5NQpdk_eD9_ElhxD-D1S65NxuGUc-gjJ5aHRGkAftv0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP387076.RA5NQpdk_eD9_ElhxD-D1S65NxuGUc-gjJ5aHRGkAftv0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP387076.RA5NQpdk_eD9_ElhxD-D1S65NxuGUc-gjJ5aHRGkAftv0130_provenance.
- NP387076.RA5NQpdk_eD9_ElhxD-D1S65NxuGUc-gjJ5aHRGkAftv0130_assertion description "[Moreover, combination of camptothecin and Ad-E2F-1 has an additive antitumor effect in an in vivo nude mouse xenograft model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP387076.RA5NQpdk_eD9_ElhxD-D1S65NxuGUc-gjJ5aHRGkAftv0130_provenance.
- NP387076.RA5NQpdk_eD9_ElhxD-D1S65NxuGUc-gjJ5aHRGkAftv0130_assertion evidence source_evidence_literature NP387076.RA5NQpdk_eD9_ElhxD-D1S65NxuGUc-gjJ5aHRGkAftv0130_provenance.
- NP387076.RA5NQpdk_eD9_ElhxD-D1S65NxuGUc-gjJ5aHRGkAftv0130_assertion SIO_000772 12637937 NP387076.RA5NQpdk_eD9_ElhxD-D1S65NxuGUc-gjJ5aHRGkAftv0130_provenance.
- NP387076.RA5NQpdk_eD9_ElhxD-D1S65NxuGUc-gjJ5aHRGkAftv0130_assertion wasDerivedFrom befree-2016 NP387076.RA5NQpdk_eD9_ElhxD-D1S65NxuGUc-gjJ5aHRGkAftv0130_provenance.
- NP387076.RA5NQpdk_eD9_ElhxD-D1S65NxuGUc-gjJ5aHRGkAftv0130_assertion wasGeneratedBy ECO_0000203 NP387076.RA5NQpdk_eD9_ElhxD-D1S65NxuGUc-gjJ5aHRGkAftv0130_provenance.
- befree-2016 importedOn "2016-02-19" NP387076.RA5NQpdk_eD9_ElhxD-D1S65NxuGUc-gjJ5aHRGkAftv0130_provenance.